Trial Profile
A multicenter, randomized, double-blind, placebo-controlled clinical trial investigating the safety and efficacy of NI-0401 in patients with newly diagnosed Type 1 Diabetes Mellitus (T1D)
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 28 Jan 2020
Price :
$35
*
At a glance
- Drugs Foralumab (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Light Chain Bioscience
- 02 Jun 2011 New trial record